Mobile

A phase II/III, multi-center, randomized, 4-week, double-blind, parallel group, placebo and active-controlled trial of the safety and efficacy of RO4917838 vs. placebo in patients with an acute exacer...

Update Il y a 4 ans
Reference: EUCTR2010-021984-33

A phase II/III, multi-center, randomized, 4-week, double-blind, parallel group, placebo and active-controlled trial of the safety and efficacy of RO4917838 vs. placebo in patients with an acute exacerbation of schizophrenia

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

�Change in Positive and Negative Syndrome Scale (PANSS) total score [ Time Frame: from baseline to Day 28 ] [ Designated as safety issue: No ] � Safety: Incidence adverse events [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Inclusion criteria

  • Acute Symptoms of Schizophrenia

Links